top of page
When Cell-Line, Animal, Tumoroid Models Are Not Enough
Farcast's proprietary techniques ensure that every tumor fragment is optimally sized, maintaining the equilibrium between stromal, tumor and immune components and retaining the spatial contexture of the original tumor microenvironment
Living, near native, heterogeneous tumor systems are ideal for determining true treatment impact and predicting tumor and immune responses
Test Multiple Regimens
Simultaneous interrogation of multiple therapies and even combinations can be tested with every patient tumor sample
Therapy Agnostic
Compatible with all therapy classes. With proven experience in bi-specific, MaBs immune checkpoint inhibitors and small molecules
Multi-Omics Approach
Integrated multi-dimensional readouts that deliver actionable insights
bottom of page